HealthTree Logo
search more_vert
close
person Sign In / Create Account
What's new in MGUS? Very interesting ASCO findings and the diagnostics you need to have as an MGUS patient with Dr. Brendan Weiss, MD
What's new in MGUS? Very interesting ASCO findings and the diagnostics you need to have as an MGUS patient with Dr. Brendan Weiss, MD image
HealthTree Podcast for Multiple Myeloma
event Jun 06, 2014 / 11:00AM MDT

Event Description

Learn about all myeloma happenings on the new Myeloma Crowd site: the first comprehensive site for myeloma patients and caregivers. Dr. Brendan Weiss, MD Abramson Cancer Center University of Pennsylvania Interview Date: June 6, 2014

 Dr. Brendan Weiss, MD of the Abramson Cancer Center specializes in MGUS treatment and precursor myeloma stages. He shares some interesting ASCO findings including panobinostat's success, how metformin (a diabetic drug) use was reviewed in 2,000 VA MGUS patients with diabetes who saw a 40% decrease in the development in myeloma. He also describes an ASCO discovery that low albumin levels seem to predict progression to myeloma. He shares that the percentage of patients with MGUS differ by age and ethnicity - roughly 1-2% in their 40s or 50s have a monoclonal protein while 4-5% over 50 have one, and 10-20% of those in their 70s or 80s have one. In the African American population, that number could be doubled. He discusses how he risk-stratifies MGUS and smoldering patients and how imaging and other tests like MRIs, PET scans, and bone marrow biopsies can or should be used for these patients. He shares common sense strategies to prevent progression. He describes his open study to observe MGUS and smoldering myeloma patients to track new biomarkers that could better identify progression (easy study to participate in!) and his study for high-risk smolderers that targets IL-6, a known growth factor for myeloma using a monoclonal antibody called siltuximab. He continues to search for general proteins part of other biological processes such as kidney injury or inflammation that could lead to future discoveries about why MGUS progresses to myeloma.    The live mPatient Myeloma Radio podcast with Dr. Brendan Weiss

Schedule & Agenda

person
Discussion
11:00AM
Dr. Brendan Weiss & Jennifer Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube